LONDON–(BUSINESS WIRE)–Nov 24, 2020–The helicobacter pylori diagnostics market is poised to develop by USD 209.59 million throughout 2020-2024, progressing at a CAGR of over 8% throughout the forecast interval. Technavio expects the market to have a optimistic impression because of the unfold of the COVID-19 pandemic. Apart from, the rising prevalence of H. pylori-associated illnesses equivalent to abdomen most cancers has led distributors available in the market to extend their R&D efforts to develop novel therapies and introduce improved diagnostic methods. That is rising the provision of speedy exams for the analysis of helicobacter pylori, which is influencing the market development.This press launch options multimedia. View the complete launch right here: https://www.businesswire.com/information/residence/20201124005749/en/Technavio has introduced its newest market analysis report titled International Helicobacter Pylori Diagnostics Market 2020-2024 (Graphic: Enterprise Wire).For a extra detailed evaluation,Get a Free Pattern Reportdelivered in a minuteThe market is pushed by the resistance of H. pylori to antibiotics. As well as, the examine identifies the rising shopper shift towards direct-to-consumer testing as one of many prime causes driving the helicobacter pylori diagnostics market development throughout the subsequent few years.The report segments the market by expertise and geography.Based mostly on the expertise, the market noticed most development within the immunoassays molecular diagnostics section in 2019. The section might be pushed by new product launches over the forecast interval.Based mostly on geography, North America led the market with a 39% share in 2019. The expansion of the market in North America is attributed to the rising prevalence of peptic ulcer illness, abdomen most cancers, and gastritis within the area.The report on the helicobacter pylori diagnostics market supplies a holistic replace, market dimension and forecast, traits, development drivers, and challenges, in addition to vendor evaluation. The report affords an up-to-date evaluation concerning the present international market situation, the most recent traits and drivers, and the general market setting.This report presents an in depth image of the market by the way in which of examine, synthesis, and summation of information from a number of sources by an evaluation of key parameters.The helicobacter pylori diagnostics market covers the next areas:Helicobacter Pylori Diagnostics Market SizingHelicobacter Pylori Diagnostics Market ForecastHelicobacter Pylori Diagnostics Market AnalysisCompanies MentionedAbbott LaboratoriesBectonDickinson and Co.bioMérieux SABio-Rad Laboratories Inc.Cardinal Well being Inc.F. Hoffmann-La Roche Ltd.Omega Diagnostics Group PlcQIAGEN N.V.Quest Diagnostics Inc.and Thermo Fisher Scientific Inc. Associated Studies onHealth CareInclude:International Gonorrhea Therapeutics Market – International gonorrhea therapeutics market is segmented by remedy (monotherapy and mixture remedy) and geography (Asia, Europe, North America, and ROW). Click on and get a FREE pattern report in minutesKey Subjects Lined:Government SummaryMarket LandscapeMarket ecosystemValue chain analysisMarket SizingMarket definitionMarket section analysisMarket dimension 2019Market outlook: Forecast for 2019 – 20245 Forces AnalysisFive Forces SummaryBargaining energy of buyersBargaining energy of suppliersThreat of latest entrantsThreat of substitutesThreat of rivalryMarket conditionMarket Segmentation by TechnologyMarket segmentsComparison by TechnologyImmunoassays – Market dimension and forecast 2019-2024Molecular diagnostics – Market dimension and forecast 2019-2024POC – Market dimension and forecast 2019-2024Market alternative by TechnologyCustomer landscapeGeographic LandscapeGeographic segmentationGeographic comparisonNorth America – Market dimension and forecast 2019-2024Europe – Market dimension and forecast 2019-2024APAC – Market dimension and forecast 2019-2024ROW – Market dimension and forecast 2019-2024Key main countriesMarket alternative by geographyVolume driver – Demand led growthVolume driver – Exterior factorsMarket challengesMarket trendsVendor LandscapeVendor landscapeLandscape disruptionVendor AnalysisVendors coveredMarket positioning of vendorsAbbott LaboratoriesbioMérieux SABio-Rad Laboratories Inc.Cardinal Well being Inc.F. Hoffmann-La Roche Ltd.Omega Diagnostics Group PlcQIAGEN N.V.Quest Diagnostics Inc.Thermo Fisher Scientific Inc.AppendixScope of the reportCurrency conversion charges for US$Analysis methodologyList of abbreviationsTechnavio suggests three forecast situations (optimistic, possible, and pessimistic) contemplating the impression of COVID-19. Technavio’s in-depth analysis has direct and oblique COVID-19 impacted market analysis experiences.Register for a free trial in the present day and acquire prompt entry to 17,000+ market analysis experiences.Technavio’s SUBSCRIPTION platformAbout UsTechnavio is a number one international expertise analysis and advisory firm. Their analysis and evaluation focuses on rising market traits and supplies actionable insights to assist companies determine market alternatives and develop efficient methods to optimize their market positions. With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 experiences and counting, overlaying 800 applied sciences, spanning throughout 50 nations. Their consumer base consists of enterprises of all sizes, together with greater than 100 Fortune 500 corporations. This rising consumer base depends on Technavio’s complete protection, in depth analysis, and actionable market insights to determine alternatives in present and potential markets and assess their aggressive positions inside altering market situations.View supply model on businesswire.com:https://www.businesswire.com/information/residence/20201124005749/en/CONTACT: Technavio ResearchJesse MaidaMedia & Advertising and marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200E mail:media@technavio.comWebsite:www.technavio.com/KEYWORD:INDUSTRY KEYWORD: OTHER HEALTH HEALTH SCIENCE RESEARCH CLINICAL TRIALSSOURCE: Technavio ResearchCopyright Enterprise Wire 2020.PUB: 11/24/2020 08:15 PM/DISC: 11/24/2020 08:15 PMhttp://www.businesswire.com/information/residence/20201124005749/en
Copyright Enterprise Wire 2020.
